Diabetes mellitus research essay

Intensive diabetes management has the goal of achieving euglycemia or near-normal glycemia. This approach requires multiple resources including thorough and continuing patient education, comprehensive recording of plasma glucose measurements and nutrition intake by the patient, and a variable insulin regimen that matches glucose intake and insulin dose. Insulin regimens usually include multiple-component insulin regimens, multiple daily injections (MDI), or insulin infusion devices. Mean blood glucose levels of 150 mg/dl can be achieved, with HbA1c 7% of the total hemoglobin. The patients on intensive therapy showed a 60% reduction in the long term complications of diabetes-retinopathy, nephropathy and neuropathy- compared with patients receiving standard care. This confirms that the complications of diabetes are related to an elevation of plasma glucose.

Type 1 and Type 2 diabetes impede a person’s carefree life. When breakdown of glucose is stopped completely, body uses fat and protein for producing the energy. Due to this mechanism symptoms like polydipsia, polyuria, polyphegia, and excessive weightloss can be observed in a diabetic. Desired blood sugar of human body should be between 70 mg/dl -110 mg/dl at fasting state. If blood sugar is less than 70 mg/dl, it is termed as hypoglycemia and if more than 110 mg /dl, it’s hyperglycemia.

Diabetes is the primary reason for adult blindness, end-stage renal disease (ESRD), gangrene and amputations. Overweight, lack of exercise, family history and stress increase the likelihood of diabetes. When blood sugar level is constantly high it leads to kidney failure, cardiovascular problems and neuropathy. Patients with diabetes are 4 times more likely to have coronary heart disease and stroke. In addition, Gestational diabetes is more dangerous for pregnant women and their fetus.

Though, Diabetes mellitus is not completely curable but, it is controllable to a great extent. So, you need to have thorough diabetes information to manage this it successfully. The control of diabetes mostly depends on the patient and it is his/her responsibility to take care of their diet, exercise and medication. Advances in diabetes research have led to better ways of controlling diabetes and treating its complications. Hence they include:-

Within the E08 – E13 code categories, there are approximately 200 specific codes that describe diabetes with various associated manifestations or complications, or about 40 codes in each code category. These specific codes are organized into nine code sections under each of the five diabetes code categories describing diabetes with various complications, including ketoacidosis (), kidney complications (), ophthalmic complications (), neurological complications (), circulatory complications (), other specified complications (), unspecified complications () and diabetes without complications (). A single ICD-10 code can therefore be used to describe patients with diabetes and its associated complications, if any. An additional code, (), identifies patients treated with insulin to control their diabetes.

Sasigarn A Bowden, MD  Associate Professor of Pediatrics, Section of Pediatric Endocrinology, Metabolism and Diabetes, Department of Pediatrics, Ohio State University College of Medicine; Pediatric Endocrinologist, Associate Fellowship Program Director, Division of Endocrinology, Nationwide Children’s Hospital; Affiliate Faculty/Principal Investigator, Center for Clinical Translational Research, Research Institute at Nationwide Children’s Hospital

Sasigarn A Bowden, MD is a member of the following medical societies: American Society for Bone and Mineral Research , Central Ohio Pediatric Society, Endocrine Society , International Society for Pediatric and Adolescent Diabetes , Pediatric Endocrine Society , Society for Pediatric Research

Disclosure: Nothing to disclose.

Diabetes mellitus research essay

diabetes mellitus research essay

Sasigarn A Bowden, MD  Associate Professor of Pediatrics, Section of Pediatric Endocrinology, Metabolism and Diabetes, Department of Pediatrics, Ohio State University College of Medicine; Pediatric Endocrinologist, Associate Fellowship Program Director, Division of Endocrinology, Nationwide Children’s Hospital; Affiliate Faculty/Principal Investigator, Center for Clinical Translational Research, Research Institute at Nationwide Children’s Hospital

Sasigarn A Bowden, MD is a member of the following medical societies: American Society for Bone and Mineral Research , Central Ohio Pediatric Society, Endocrine Society , International Society for Pediatric and Adolescent Diabetes , Pediatric Endocrine Society , Society for Pediatric Research

Disclosure: Nothing to disclose.

Media:

diabetes mellitus research essaydiabetes mellitus research essaydiabetes mellitus research essaydiabetes mellitus research essay